A special focused magnet, designed for the use in the magnetic targeted drug delivery system, was constructed. The theoretical calculation of the adhesion condition for a magnetic uid drop in magnetič eld with obtained design showed that the constructed focused magnet generates a sufˇcient magnetic force for the capture of a magnetic drop on the vessel wall and can be used 1.5Ä2 cm deeper in an organism compared with the prism permanent magnet, which can enable non-invasivity of the magnetic drug targeting procedure. The maximal values for magneticˇeld and gradient of magneticˇeld are 0.38 T and 101 T/m, respectively. μ¸É·μ¥´¸ ¶¥Í¨ ²Ó´μ¸Ëμ±Ê¸¨·μ¢ ´´Ò°³ £´¨É, ¶·¥¤´ §´ Î¥´´Ò°¤²Ö ¤μ¸É ¢±¨³ £´¨É´ÒÌ ²¥-± ·¸É¢¥´´ÒÌ ¶·¥ ¶ · Éμ¢. '¥μ·¥É¨Î¥¸±¨° ´ ²¨ § Ê¸²μ¢¨Ö ¤£¥ §¨¨³ £´¨É´μ°± ¶²¨¢ ³ £´¨É´μ³ ¶μ²¥ · §· ¡μÉ ´´μ£μ ³ £´¨É ¶μ± § ², ÎÉμ ¶μ¸²¥¤´¨°£¥´¥·¨·Ê¥É ¤μ¸É ÉμÎ´ÊÕ ³ £´¨É´ÊÕ¸¨²Ê ¤²Ö § Ì¢ É ³ £´¨É´μ°± ¶²¨´ ¸É¥´±¥¸μ¸Ê¤ , ¶·μ´¨± ÕÐÊÕ´ 1,5Ä2¸³ £²Ê¡¦¥ ¢ μ·£ ´¨ §³ ¶μ¸· ¢´¥-¨Õ¸³ £´¨É´Ò³ ¶μ²¥³ ¶μ¸ÉμÖ´´μ£μ ³ £´¨É , ÎÉμ ¶μ §¢μ²Ö¥É ¡¥¸±μ´É ±É´μ ¤μ¸É ¢²ÖÉÓ ³ £´¨É´Ò°² ¥± ·¸É¢¥´´Ò° ¶·¥ ¶ · É. OE ±¸¨³ ²Ó´Ò¥ §´ Î¥´¨Ö ¤²Ö ³ £´¨É´μ£μ ¶μ²Ö¨£· ¤¨¥´É ³ £´¨É´μ£μ ¶μ²Ö 0,38 '²¨101 '²/³¸μμÉ¢¥É¸É¢¥´´μ.
PACS: 47.63.mh
The difference between success and failure of chemotherapy depends not only on the drug itself but also on how it is delivered to its target. One of the major problems in pharmacotherapy is the delivery of drugs to a speciˇc location and maintenance of its location for the desired length of time. Because of the relatively nonspeciˇc action of chemotherapeutic agents, there is almost always some toxicity to normal tissues. Therefore, it is of great importance to be able to selectively target the magnetically labelled drug to the tumor target as precisely as possible, to reduce resulting systemic toxic side effects from generalized systemic distribution and to be able to use a much smaller dose, which would further lead to a reduction of toxicity. The method of magnetic drug targeting is dependent on physical properties, concentration and amount of applied nanoparticles, on type of binding of the drugs, on the physiological parameters of the patient and of course on magnetic force, which is deˇned by itsˇeld andˇeld gradient [1] . Guided transport of biologically active substances to the target organ allows creating an optimum therapeutic concentration of the drug in the desired part of organism, while keeping the total injected dose low [2Ä4] . Current research on methods to target chemotherapy drugs in the human body includes the investigation of biocompatible magnetic nano-carrier systems, e.g., magnetic liquids such as ferro uids. The use of biocompatible magnetic uid as potential drug carrier appears to be a promising technique. Due to their superparamagnetic properties, the magnetic uid drops can be precisely transported, positioned and controlled in desirable parts of blood vessels or hollow organs with the help of an external magneticˇeld. The motion of magnetic drop within the body is controlled by the combination of magnetic force and a hemodynamic drag force due to blood ow. The models which investigate the interaction of an external magneticˇeld with blood ow containing a magnetic carrier substance are based on the Maxwell and NavierÄStokes equations, where a static magneticˇeld is coupled to uid ow. This is achieved by adding a magnetic volume force to the NavierÄStokes equations, which stems from the solution of magneticˇeld problem [5] . In order to effectively overcome the in uence of blood ow the magnetic force must be larger than the drag force. The conditions for holding a magnetic uid drop on a blood vessel wall were investigated by Voltairas et al. [6] . In this work the nonuniformity of considered magneticˇeld is higher only close to the magnetic pole, what was regarded as a major technical problem that has to be resolved in order for the drug targeting to remain essentially non-invasive. The aim of our work was to construct a focused magnet, which enables one to achieve maximal magnetic force in deeper position, to map its magneticˇeld and toˇnd the adhesion condition for a magnetic uid drop in magneticˇeld with obtained design.
Voltairas et al. [6] presented a self-consistent ferrohydrodynamic theory of magnetic drug targeting and examined a model case to account for adhesion. They obtained an upper bound of the mean blood ow velocity as a function of the applied magneticˇeld, which was considered to be produced by a point source located outside the body at x = −δ, y = 0, z = ζ (δ, ζ > 0, nonuniformity higher only close to magnetic pole) and had the form
where m is the magnetic dipole moment. The magnetic point source was oriented at an angle
with respect to the x axis. Thus, instead of one adhesion condition, Voltairas et al. [6] obtained two equations (3) and (4), and the dependence of blood ow velocity on the applied magneticˇeld was parameterized as
and
The obtained law
gives an upper bound of the mean blood ow velocity, at which the applied magneticˇeld is able to capture a magnetic drug drop on the blood vessel wall. The used magneticˇeld geometry does not give sufˇcient magneticˇeld and magneticˇeld gradient to apply this magnet in deeper position in organism, therefore we used concept of focusing of magneticˇeld to achieve better results for magnetic drug targeting. The proposed magnetic system is given in Fig. 1 . To construct the map of magneticˇeld is not very easy task and for this we used GRID computing.
Consecutively we have tested the constructed magnet from the point of magneticˇeld induction and magneticˇeld gradient, respectively. The magneticˇeld of the manufactured focused magnet was measured by 3D Hall probe. The maximal value of the magneticˇeld near the magnet surface (0.35 mm) was estimated to be 0.38 T. For example, the magnetič eld gradient at z = 0 was estimated to be 101 T/m. The measured magneticˇeld by Hall probe was used for the construction of a map of the magneticˇeld of the focused magnet. The examples of all componets of magneticˇeld, i.e., B x (x, y, z), B y (x, y, z), B z (x, y, z), are illustrated in Figs. 2Ä4 (for y = 0.0). As an example, the function used forˇtting of magneticˇeld B x (x, y, z) is given in Appendix.
In effort to test the ability of the magnet to generate a strong magneticˇeld in deeper position, the found proˇle of its magneticˇeld was used in the numerical calculation following [6] . The resuls are given in the table.
In summary, a focused magnet consisting of 36 prisms with pyramidal shape was manufactured, generating higher magneticˇeld and higher magneticˇeld gradient as compared with classical prism. The magneticˇeld of the focused magnet was mapped and its proˇle was used in numerical calculations, which yielded the upper bound of the mean blood ow velocity, at which the applied magneticˇeld is able to capture a magnetic drug drop on the blood vessel wall. The obtained results veriˇed the ability of the magnet to generate a sufˇcient magnetic force in deeper position (2.5Ä3 cm), which could contribute to the non-invasivity of the magnetic drug targeting procedure. 
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